IMNN Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

-2.195

-32.67%

0.000

-100%

0.000

-100%

Estimates Revision

The market is revising No Change the revenue expectations for Imunon, Inc. (IMNN) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -24.73%.

EPS Estimates for FY2025

Revise Downward

-2.55%

In Past 3 Month

Stock Price

Go Down

-24.73%

In Past 3 Month

1 Analyst Rating

Wall Street analysts forecast IMNN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IMNN is 12.00 USD with a low forecast of 12.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 4.200

Low

12.00

Averages

12.00

High

12.00

Current: 4.200

Low

12.00

Averages

12.00

High

12.00

D. Boral Capital

Jason Kolbert

Buy

Hold

downgrade

2025-05-19

Reason

D. Boral Capital

Jason Kolbert

Price Target

2025-05-19

downgrade

Buy

Hold

Reason

Boral Capital

D. Boral

Buy

downgrade

$29 -> $17

2025-05-13

Reason

Boral Capital

D. Boral

Price Target

$29 -> $17

2025-05-13

downgrade

Buy

Reason

HC Wainwright & Co.

Emily Bodnar

Strong Buy

Reiterates

$14

2025-03-26

Reason

HC Wainwright & Co.

Emily Bodnar

Price Target

$14

2025-03-26

Reiterates

Strong Buy

Reason

D. Boral Capital

Jason Kolbert

Strong Buy

Maintains

$29

2025-03-24

Reason

D. Boral Capital

Jason Kolbert

Price Target

$29

2025-03-24

Maintains

Strong Buy

Reason

D. Boral Capital

Jason Kolbert

Strong Buy

Maintains

$29

2025-02-27

Reason

D. Boral Capital

Jason Kolbert

Price Target

$29

2025-02-27

Maintains

Strong Buy

Reason

D. Boral Capital

Jason Kolbert

Strong Buy

Maintains

$29

2025-02-19

Reason

D. Boral Capital

Jason Kolbert

Price Target

$29

2025-02-19

Maintains

Strong Buy

Reason

Valuation Metrics

The current forward P/E ratio for Imunon Inc (IMNN.O) is -0.81, compared to its 5-year average forward P/E of -1.43. For a more detailed relative valuation and DCF analysis to assess Imunon Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-1.43

Current PE

-0.81

Overvalued PE

0.20

Undervalued PE

-3.06

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

39.75

Current PS

0.00

Overvalued PS

108.95

Undervalued PS

-29.46

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

IMNN News & Events

Events Timeline

No data

News

9.5

11-13NASDAQ.COM

Imunon (IMNN) Q3 2025 Earnings Conference Call Transcript

9.5

11-13Newsfilter

IMUNON Releases Financial Results for Q3 2025 and Offers Business Update

1.0

11-10Newsfilter

IMUNON's Public Webcast Showcases Resilience and Innovation in the Quest for the First Approved Ovarian Cancer Immunotherapy

People Also Watch

Frequently Asked Questions

What is Imunon Inc (IMNN) stock price today?

The current price of IMNN is 4.2 USD — it has increased 1.2 % in the last trading day.

What is Imunon Inc (IMNN)'s business?

Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases, constituting a differentiating approach from conventional therapies. The Company is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the gene-based delivery of cytokines and other therapeutic proteins in the treatment of solid tumors. The second modality, PlaCCine, is developed for the gene delivery of viral antigens that can elicit a strong immunological response. The Company’s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer that has completed Phase 2 development. IMNN-001 works by instructing the body to produce safe and durable levels of powerful cancer-fighting molecules, such as interleukin-12 and interferon gamma, at the tumor site.

What is the price predicton of IMNN Stock?

What is Imunon Inc (IMNN)'s revenue for the last quarter?

Imunon Inc revenue for the last quarter amounts to 0.00 USD, decreased % YoY.

What is Imunon Inc (IMNN)'s earnings per share (EPS) for the last quarter?

Imunon Inc. EPS for the last quarter amounts to -1.01 USD, decreased -76.94 % YoY.

What changes have occurred in the market's expectations for Imunon Inc (IMNN)'s fundamentals?

How many employees does Imunon Inc (IMNN). have?

Imunon Inc (IMNN) has 25 emplpoyees as of December 15 2025.

What is Imunon Inc (IMNN) market cap?

Today IMNN has the market capitalization of 12.74M USD.